ELAB Stock Analysis: Buy, Sell, or Hold?

ELAB - PMGC Holdings Inc. Common Stock

PHARMACEUTICAL PREPARATIONS
$2.66
-0.69 (-20.60%) ▼
5d: -22.22%
30d: +87.32%
90d: -55.11%
WAIT
LOW Confidence
Last Updated: February 2, 2026
Earnings: Mar 26, 2026

Get Alerted When ELAB Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

💡
Bottom Line:
⏸️ WAIT FOR STABILIZATION: ELAB is down 22.2% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.

In-depth Analysis How we analyze

Valuation Analysis: ELAB is currently trading at $2.66, which is considered slightly low relative to its 30-day fair value range of $2.05 to $4.70.

Technical Outlook: Technically, ELAB is in a downtrend. Immediate support is located at $2.57, while resistance sits at $3.84. Short-term momentum is weak, with the stock down 20.6% recently.

Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Current signals suggest waiting for a better entry point before initiating new positions.

Quick Decision Summary

Current Position SLIGHTLY LOW
Fair Price Range $2.05 - $4.70
Company Quality Score 52/100 (HOLD)
Volume Confirmation HIGH
Confidence Score 74.7%

All Signals

  • BULLISH: Price oversold vs 30-day range
  • NEUTRAL: Mixed technical signals (40/100)
  • BULLISH: High volume confirmation
  • BEARISH: Downward momentum (-20.6%)
  • WARNING: Recommendation downgraded due to -22.2% 5-day decline - wait for stabilization

Fair Price Analysis

30-Day Fair Range $2.05 - $4.70
Current vs Fair Value SLIGHTLY LOW

Support & Resistance Levels

Support Level $2.57
Resistance Level $3.84
Current Trend Downtrend

Fundamental Context

Revenue Growth (YoY) -45.8%
Last updated: February 03, 2026 11:34 AM ET
Data refreshes hourly during market hours. Next update: 12:34 PM
🔥 Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Technical Signals Check

Top Rated Biotechnology Stocks

Top-rated stocks in Biotechnology by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
BMRN
Biomarin Pharmaceutical …
STRONG BUY
29 analysts
$91 61 BUY
KYMR
Kymera Therapeutics Inc
STRONG BUY
20 analysts
$117 61 BUY
BNTX
BioNTech SE
STRONG BUY
21 analysts
$140 52 HOLD
NRIX
Nurix Therapeutics Inc
STRONG BUY
18 analysts
$30 53 HOLD
IMVT
Immunovant Inc
STRONG BUY
14 analysts
$40 57 HOLD

More Analysis for ELAB

ELAB Technical Chart ELAB Price Prediction ELAB Earnings Date ELAB Investment Advisor ELAB Fair Price Analyzer ELAB Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals